These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29955512)

  • 1. Early detection of an atypical presentation of neuroleptic malignant syndrome: A case report.
    Vickery PB; Meadowcraft L; Vickery SB
    Ment Health Clin; 2017 May; 7(3):137-142. PubMed ID: 29955512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome associated with ziprasidone in an adolescent.
    Leibold J; Patel V; Hasan RA
    Clin Ther; 2004 Jul; 26(7):1105-8. PubMed ID: 15336475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of 17 catatonic patients diagnosed with neuroleptic malignant syndrome.
    White DA; Robins AH
    CNS Spectr; 2000 Jul; 5(7):58-65. PubMed ID: 18197157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
    Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
    J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic Malignant Syndrome.
    Pileggi DJ; Cook AM
    Ann Pharmacother; 2016 Nov; 50(11):973-981. PubMed ID: 27423483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report].
    Mishima T; Tsuboi Y; Higuchi MA; Tsugawa J; Obata T; Yamada T
    Brain Nerve; 2011 May; 63(5):503-7. PubMed ID: 21515931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.
    Ohi K; Kuwata A; Shimada T; Yasuyama T; Nitta Y; Uehara T; Kawasaki Y
    Medicine (Baltimore); 2017 Apr; 96(16):e6566. PubMed ID: 28422845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome in a patient on long-term olanzapine treatment at a stable dose: Successful treatment with dantrolene.
    Kouparanis A; Bozikas A; Spilioti M; Tziomalos K
    Brain Inj; 2015; 29(5):658-60. PubMed ID: 25625410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
    Reeves RR; Mack JE; Torres RA
    Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone-induced neuroleptic malignant syndrome.
    Sharma R; Trappler B; Ng YK; Leeman CP
    Ann Pharmacother; 1996; 30(7-8):775-8. PubMed ID: 8826559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant Catatonia Versus Neuroleptic Malignant Syndrome.
    Desai S; Hirachan T; Toma A; Gerolemou A
    Cureus; 2021 Jun; 13(6):e15818. PubMed ID: 34306883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenge with atypical antipsychotic drugs in risperidone induced neuroleptic malignant syndrome: a case report.
    Mendhekar DN; Jiloha RC; Mehndiratta MM; War L
    Indian J Psychiatry; 2002 Oct; 44(4):387-90. PubMed ID: 21206609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic Malignant Syndrome or Catatonia? A Case Report.
    Rodriguez S; Dufendach KA; Weinreib RM
    J Crit Care Med (Targu Mures); 2020 Jul; 6(3):190-193. PubMed ID: 32864466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome secondary to quetiapine.
    Gortney JS; Fagan A; Kissack JC
    Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical neuroleptic malignant syndrome - A case report.
    Vellekkatt F; Kuppili PP; Bharadwaj B; Menon V
    Asian J Psychiatr; 2019 Jun; 43():7-8. PubMed ID: 31071486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome].
    Murak E
    Psychiatr Pol; 1995; 29(3):349-58. PubMed ID: 7652088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome: guidelines for treatment and reinstitution of neuroleptics.
    Olmsted TR
    South Med J; 1988 Jul; 81(7):888-91. PubMed ID: 2899358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.